Table 4.
Comparison of adjusted outcomes of treatment groups with Concomitant as reference
| Adjusted odds ratio or β-coefficient (95% CI) | P value | |
|---|---|---|
| Mortality | ||
| Early-Staged | 0.93 (0.20-4.25) | .93 |
| Late-Staged | 1.48 (0.45-4.86) | .52 |
| Stroke | ||
| Early-Staged | 1.38 (0.48-4.01) | .55 |
| Late-Staged | 1.65 (0.76-3.57) | .21 |
| Post-procedural hemorrhage | ||
| Early-Staged | 1.86 (0.43-8.09) | .41 |
| Late-Staged | 1.45 (0.41-5.08) | .56 |
| Blood transfusion | ||
| Early-Staged | 0.92 (0.53-1.57) | .75 |
| Late-Staged | 1.18 (0.78-1.79) | .43 |
| Acute kidney injury | ||
| Early-Staged | 2.68 (1.57-4.55) | <.001 |
| Late-Staged | 1.97 (1.29-2.99) | .002 |
| Pacemaker implantation | ||
| Early-Staged | 1.47 (0.94-2.28) | .088 |
| Late-Staged | 0.98 (0.68-1.41) | .91 |
| Non-home discharge | ||
| Early-Staged | 5.60 (3.65-8.59) | <.001 |
| Late-Staged | 2.87 (2.14-3.86) | <.001 |
| Post-TAVR length of stay, days | ||
| Early-Staged | 0.5 (−0.2 to 1.2) | .14 |
| Late-Staged | 0.3 (−0.1 to 0.7) | .21 |
| Total length of stay, days | ||
| Early-Staged | 3.0 (2.0-4.1) | <.001 |
| Late-Staged | 4.7 (4.0-5.3) | <.001 |
| Total hospitalization costs per $1000 | ||
| Early-Staged | 6.6 (1.4-11.9) | .014 |
| Late-Staged | 13.3 (9.2-17.4) | <.001 |
| 30-Day readmission | ||
| Early-Staged | 1.35 (0.86-2.12) | .19 |
| Late-Staged | 1.27 (0.86-1.87) | .24 |
Binary outcomes are reported as adjusted odds ratio whereas continuous outcomes are reported as β-coefficient. CI, Confidence interval; TAVR, transcatheter aortic valve replacement.